Is the course of gastroesophageal reflux disease progressive? A 21-year follow-up.

scientific article published in January 2009

Is the course of gastroesophageal reflux disease progressive? A 21-year follow-up. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/00365520903314157
P8608Fatcat IDrelease_lpe4g77z6vgrndloemx5krwoha
P698PubMed publication ID19891578

P50authorDan FalkenbackQ56600433
P2093author name stringJan Johansson
Stefan Oberg
Folke Johnsson
P2860cites workEndoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classificationQ24670182
Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial diseaseQ31065372
Initial validation of a diagnostic questionnaire for gastroesophageal reflux diseaseQ34150681
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of lifeQ34409506
Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux diseaseQ34528647
Heartburn--the acid testQ34532576
Identifying patients with gastroesophageal reflux disease: validation of a practical screening toolQ34787785
Review article: Helicobacter pylori and reflux diseaseQ35058182
Improving Health-Related Quality of Life in Gastro-Oesophageal Reflux DiseaseQ35549779
Review article: approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder?Q35630057
Review of the quality of life and burden of illness in gastroesophageal reflux diseaseQ35895313
Systematic review: does gastro-oesophageal reflux disease progress?Q36520770
The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trialsQ36665563
Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristicsQ36716400
Gastroesophageal reflux disease is a progressive diseaseQ36767347
The Swedish SF-36 Health Survey--I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in SwedenQ36790923
Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken 'on-demand'.Q36860944
The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease.Q37020527
Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based studyQ37162117
Helicobacter pylori and gastroesophageal reflux disease: a case-control studyQ37270990
Quality of life in relation to symptoms in patients with gastro‐oesophageal reflux disease — an analysis based on the ProGERD initiativeQ39389320
Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish communityQ39741857
The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposureQ41609753
Gastroesophageal reflux disease and mucosal injury with emphasis on short-segment Barrett's esophagus and duodenogastroesophageal refluxQ41686367
Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease.Q46034146
Symptoms in gastro-oesophageal reflux diseaseQ46905458
Factor structure of the Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire evaluated in patients with heartburn predominant reflux diseaseQ47597774
The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life AssessmentQ47743441
The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life AssessmentQ47743453
The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: results from normative populationQ47743608
The Swedish SF-36 Health Survey II. Evaluation of clinical validity: results from population studies of elderly and women in GothenborgQ47743620
Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosaQ50658043
Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.Q50740079
The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groupsQ50743733
Three- to 4.5-year prospective study of prognostic indicators in gastro-oesophageal reflux diseaseQ50855874
The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus: The Prague C & M CriteriaQ58104636
P433issue11
P921main subjectgastroesophageal reflux diseaseQ223591
P304page(s)1277-1287
P577publication date2009-01-01
P1433published inScandinavian Journal of GastroenterologyQ7429960
P1476titleIs the course of gastroesophageal reflux disease progressive? A 21-year follow-up
P478volume44

Reverse relations

cites work (P2860)
Q36220260Alterations of Mast Cells in the Esophageal Mucosa of the Patients With Non-Erosive Reflux Disease
Q39256525Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study
Q42628118Longitudinal study of gastroesophageal reflux and erosive tooth wear
Q36904153Necrotizing sialometaplasia-like change of the esophageal submucosal glands is associated with Barrett's esophagus.
Q35172943Non-erosive and uncomplicated erosive reflux diseases: Difference in physiopathological and symptom pattern.
Q57074637Proposed approach to the challenging management of progressive gastroesophageal reflux disease
Q39013080The natural history of gastro-esophageal reflux disease: a comprehensive review.

Search more.